- Home
- PRLD vs BDSX Comparison
PRLD vs BDSX Comparison
Compare PRLD & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | BDSX |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 62.5M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PRLD | BDSX |
|---|---|---|
| Price | $2.78 | $5.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $4.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 534.1K | 61.8K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,500,000.00 | ★ $80,173,000.00 |
| Revenue This Year | N/A | $20.75 |
| Revenue Next Year | N/A | $25.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 250.00 | 22.29 |
| 52 Week Low | $0.61 | $3.44 |
| 52 Week High | $4.22 | $31.00 |
Technical Indicators
Market Signals| Indicator | PRLD | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 62.95 | 30.25 |
| Support Level | $2.37 | $5.61 |
| Resistance Level | $3.00 | $6.92 |
| Average True Range (ATR) | 0.28 | 0.54 |
| MACD | 0.03 | -0.14 |
| Stochastic Oscillator | 78.39 | 3.31 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.